These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17298478)

  • 21. Sleep disturbances associated with gastro-oesophageal reflux disease: prevalence and impact of treatment in French primary care patients.
    Cadiot G; Delaage PH; Fabry C; Soufflet C; Barthélemy P
    Dig Liver Dis; 2011 Oct; 43(10):784-7. PubMed ID: 21752736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extra-oesophageal presentation of gastro-oesophageal reflux disease.
    Rathod NR
    J Indian Med Assoc; 2010 Jan; 108(1):18-20, 22. PubMed ID: 20839575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Water load test before and after PPI therapy in patients with gastro-oesophageal reflux disease.
    Battaglia E; Grassini M; Navino M; Niola P; Verna C; Mazzocchi A; Clerici C; Morelli A; Bassotti G
    Dig Liver Dis; 2007 Dec; 39(12):1052-6. PubMed ID: 17913607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chest pain from gastroesophageal reflux disease in patients with coronary artery disease.
    Liuzzo JP; Ambrose JA
    Cardiol Rev; 2005; 13(4):167-73. PubMed ID: 15949050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.
    Zerbib F; Belhocine K; Simon M; Capdepont M; Mion F; Bruley des Varannes S; Galmiche JP
    Gut; 2012 Apr; 61(4):501-6. PubMed ID: 21997546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy.
    Qua CS; Wong CH; Gopala K; Goh KL
    Aliment Pharmacol Ther; 2007 Feb; 25(3):287-95. PubMed ID: 17269990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for gastro-oesophageal reflux disease symptoms: a community study.
    Mohammed I; Nightingale P; Trudgill NJ
    Aliment Pharmacol Ther; 2005 Apr; 21(7):821-7. PubMed ID: 15801917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sleep dysfunction in patients with gastro-oesophageal reflux disease: prevalence and response to GERD therapy, a pilot study.
    Chand N; Johnson DA; Tabangin M; Ware JC
    Aliment Pharmacol Ther; 2004 Nov; 20(9):969-74. PubMed ID: 15521844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of gastro-oesophageal reflux disease (GORD) in patients with obstructive lung disease using exhaled breath profiling.
    Timms C; Thomas PS; Yates DH
    J Breath Res; 2012 Mar; 6(1):016003. PubMed ID: 22233591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevalence of gastro-oesophageal reflux disease in general practice].
    Hollenz M; Stolte M; Labenz J
    Dtsch Med Wochenschr; 2002 May; 127(19):1007-12. PubMed ID: 11997867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of respiratory symptoms with dual pH monitoring in patients with gastro-oesophageal reflux disease.
    Kauer WK; Stein HJ; Möbius C; Siewert JR
    Br J Surg; 2004 Jul; 91(7):867-71. PubMed ID: 15227693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of common cardiac drugs on gastroesophageal reflux disease: multicenter questionnaire survey.
    Nakaji G; Fujihara M; Fukata M; Yasuda S; Odashiro K; Maruyama T; Akashi K
    Int J Clin Pharmacol Ther; 2011 Sep; 49(9):555-62. PubMed ID: 21888868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chest pain without established ischaemic heart disease in primary care patients: associated comorbidities and mortality.
    Ruigómez A; Massó-González EL; Johansson S; Wallander MA; García-Rodríguez LA
    Br J Gen Pract; 2009 Mar; 59(560):e78-86. PubMed ID: 19275827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis: the epidemiology of noncardiac chest pain in the community.
    Ford AC; Suares NC; Talley NJ
    Aliment Pharmacol Ther; 2011 Jul; 34(2):172-80. PubMed ID: 21615436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium-channel blocking agents and chest pain.
    Gaginella TS; Maxfield DL
    Drug Intell Clin Pharm; 1988; 22(7-8):623-5. PubMed ID: 3046891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diltiazem myopathy.
    Ahmad S
    Am Heart J; 1993 Dec; 126(6):1494-5. PubMed ID: 8249821
    [No Abstract]   [Full Text] [Related]  

  • 40. Unrecognized side effects of sublingual nitrate therapy.
    Mittal SR; Mathur AK
    Int J Cardiol; 1987 Nov; 17(2):225-6. PubMed ID: 3679606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.